Roche sales and marketing update

Roche launched the Elecsys HE4 assay in the U.S. to aid in monitoring the recurrence or progressive disease in patients with epithelial ovarian cancer. The immunoassay quantifies WAP four-disulfide core domain 2 ( WFDC2; HE4) in human serum and plasma. ...